Exact Mass: 480.2173
Exact Mass Matches: 480.2173
Found 396 metabolites which its exact mass value is equals to given mass value 480.2173
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
1-[(4-Amino-3-methylphenyl)methyl]-5-(2,2-diphenylacetyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridine-6-carboxylic acid
Copanlisib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EM - Phosphatidylinositol-3-kinase (pi3k) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
6,10,11-trihydroxy-8-(3-hydroxy-3-methylbutyl)-3,3-dimethyl-9-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one
(6aR)-3-(4-hydroxy-2-methyl-6-oxocyclohexenyl)-6a-methyl-9-(2-methyloctanoyl)-6aH-furo[2,3-h]isochromene-6,8-dione|cohaerin D
3,4-dihydro-3,6,7,11-tetrahydroxy-8,9-di(3-methyl-2-butenyl)-2,2-dimethyl-pyrano[2,3-c]xanthone
1,3,7,8-tetrahydroxy-4,6,9-tris(3-methyl-2-buten-1-yl)-11H-dibenzo[b,e][1,4]dioxepin-11-one|oliveridepsidone A
Ala Tyr Ile Asp
Tyr Val Ala Glu
Ser Phe Ile Asp
Thr Val Phe Asp
Ala Asp Ile Tyr
Ala Asp Leu Tyr
Ala Asp Tyr Ile
Ala Asp Tyr Leu
Ala Glu Val Tyr
Ala Glu Tyr Val
Ala Ile Asp Tyr
Ala Ile Tyr Asp
Ala Leu Asp Tyr
Ala Leu Tyr Asp
Ala Val Glu Tyr
Ala Val Tyr Glu
Ala Tyr Asp Ile
Ala Tyr Asp Leu
Ala Tyr Glu Val
Ala Tyr Leu Asp
Ala Tyr Val Glu
Cys Cys Lys Lys
Cys Lys Cys Lys
Cys Lys Lys Cys
Asp Ala Ile Tyr
Asp Ala Leu Tyr
Asp Ala Tyr Ile
Asp Ala Tyr Leu
Asp Phe Ile Ser
Asp Phe Leu Ser
Asp Phe Ser Ile
Asp Phe Ser Leu
Asp Phe Thr Val
Asp Phe Val Thr
Asp Ile Ala Tyr
Asp Ile Phe Ser
Asp Ile Ser Phe
Asp Ile Tyr Ala
Asp Leu Ala Tyr
Asp Leu Phe Ser
Asp Leu Ser Phe
Asp Leu Tyr Ala
Asp Ser Phe Ile
Asp Ser Phe Leu
Asp Ser Ile Phe
Asp Ser Leu Phe
Asp Thr Phe Val
Asp Thr Val Phe
Asp Val Phe Thr
Asp Val Thr Phe
Asp Tyr Ala Ile
Asp Tyr Ala Leu
Asp Tyr Ile Ala
Asp Tyr Leu Ala
Glu Ala Val Tyr
Glu Ala Tyr Val
Glu Phe Ser Val
Glu Phe Val Ser
Glu Gly Ile Tyr
Glu Gly Leu Tyr
Glu Gly Tyr Ile
Glu Gly Tyr Leu
Glu Ile Gly Tyr
Glu Ile Tyr Gly
Glu Leu Gly Tyr
Glu Leu Tyr Gly
Glu Ser Phe Val
Glu Ser Val Phe
Glu Val Ala Tyr
Glu Val Phe Ser
Glu Val Ser Phe
Glu Val Tyr Ala
Glu Tyr Ala Val
Glu Tyr Gly Ile
Glu Tyr Gly Leu
Glu Tyr Ile Gly
Glu Tyr Leu Gly
Glu Tyr Val Ala
Phe Asp Ile Ser
Phe Asp Leu Ser
Phe Asp Ser Ile
Phe Asp Ser Leu
Phe Asp Thr Val
Phe Asp Val Thr
Phe Glu Ser Val
Phe Glu Val Ser
Phe Ile Asp Ser
Phe Ile Ser Asp
Phe Leu Asp Ser
Phe Leu Ser Asp
Phe Ser Asp Ile
Phe Ser Asp Leu
Phe Ser Glu Val
Phe Ser Ile Asp
Phe Ser Leu Asp
Phe Ser Val Glu
Phe Thr Asp Val
Phe Thr Val Asp
Phe Val Asp Thr
Phe Val Glu Ser
Phe Val Ser Glu
Phe Val Thr Asp
Gly Glu Ile Tyr
Gly Glu Leu Tyr
Gly Glu Tyr Ile
Gly Glu Tyr Leu
Gly Ile Glu Tyr
Gly Ile Tyr Glu
Gly Leu Glu Tyr
Gly Leu Tyr Glu
Gly Tyr Glu Ile
Gly Tyr Glu Leu
Gly Tyr Ile Glu
Gly Tyr Leu Glu
His His Ser Thr
His His Thr Ser
His Met Pro Pro
His Asn Asn Pro
His Asn Pro Asn
His Pro Met Pro
His Pro Asn Asn
His Pro Pro Met
His Ser His Thr
His Ser Thr His
His Thr His Ser
His Thr Ser His
Ile Ala Asp Tyr
Ile Ala Tyr Asp
Ile Asp Ala Tyr
Ile Asp Phe Ser
Ile Asp Ser Phe
Ile Asp Tyr Ala
Ile Glu Gly Tyr
Ile Glu Tyr Gly
Ile Phe Asp Ser
Ile Phe Ser Asp
Ile Gly Glu Tyr
Ile Gly Tyr Glu
Ile Met Met Ser
Ile Met Ser Met
Ile Ser Asp Phe
Ile Ser Phe Asp
Ile Ser Met Met
Ile Tyr Ala Asp
Ile Tyr Asp Ala
Ile Tyr Glu Gly
Ile Tyr Gly Glu
Lys Cys Cys Lys
Lys Cys Lys Cys
Lys Lys Cys Cys
Leu Ala Asp Tyr
Leu Ala Tyr Asp
Leu Asp Ala Tyr
Leu Asp Phe Ser
Leu Asp Ser Phe
Leu Asp Tyr Ala
Leu Glu Gly Tyr
Leu Glu Tyr Gly
Leu Phe Asp Ser
Leu Phe Ser Asp
Leu Gly Glu Tyr
Leu Gly Tyr Glu
Leu Met Met Ser
Leu Met Ser Met
Leu Ser Asp Phe
Leu Ser Phe Asp
Leu Ser Met Met
Leu Tyr Ala Asp
Leu Tyr Asp Ala
Leu Tyr Glu Gly
Leu Tyr Gly Glu
Met His Pro Pro
Met Ile Met Ser
Met Ile Ser Met
Met Leu Met Ser
Met Leu Ser Met
Met Met Ile Ser
Met Met Leu Ser
Met Met Ser Ile
Met Met Ser Leu
Met Met Thr Val
Met Met Val Thr
Met Pro His Pro
Met Pro Pro His
Met Ser Ile Met
Met Ser Leu Met
Met Ser Met Ile
Met Ser Met Leu
Met Thr Met Val
Met Thr Val Met
Met Val Met Thr
Met Val Thr Met
Asn His Asn Pro
Asn His Pro Asn
Asn Asn His Pro
Asn Asn Pro His
Asn Pro His Asn
Asn Pro Asn His
Pro His Met Pro
Pro His Asn Asn
Pro His Pro Met
Pro Met His Pro
Pro Met Pro His
Pro Asn His Asn
Pro Asn Asn His
Pro Pro His Met
Pro Pro Met His
Pro Thr Thr Tyr
Pro Thr Tyr Thr
Pro Tyr Thr Thr
Ser Asp Phe Ile
Ser Asp Phe Leu
Ser Asp Ile Phe
Ser Asp Leu Phe
Ser Glu Phe Val
Ser Glu Val Phe
Ser Phe Asp Ile
Ser Phe Asp Leu
Ser Phe Glu Val
Ser Phe Leu Asp
Ser Phe Val Glu
Ser His His Thr
Ser His Thr His
Ser Ile Asp Phe
Ser Ile Phe Asp
Ser Ile Met Met
Ser Leu Asp Phe
Ser Leu Phe Asp
Ser Leu Met Met
Ser Met Ile Met
Ser Met Leu Met
Ser Met Met Ile
Ser Met Met Leu
Ser Thr His His
Ser Val Glu Phe
Ser Val Phe Glu
Thr Asp Phe Val
Thr Asp Val Phe
Thr Phe Asp Val
Thr Phe Val Asp
Thr His His Ser
Thr His Ser His
Thr Met Met Val
Thr Met Val Met
Thr Pro Thr Tyr
Thr Pro Tyr Thr
Thr Ser His His
Thr Thr Pro Tyr
Thr Thr Tyr Pro
Thr Val Asp Phe
Thr Val Met Met
Thr Tyr Pro Thr
Thr Tyr Thr Pro
Val Ala Glu Tyr
Val Ala Tyr Glu
Val Asp Phe Thr
Val Asp Thr Phe
Val Glu Ala Tyr
Val Glu Phe Ser
Val Glu Ser Phe
Val Glu Tyr Ala
Val Phe Asp Thr
Val Phe Glu Ser
Val Phe Ser Glu
Val Phe Thr Asp
Val Met Met Thr
Val Met Thr Met
Val Ser Glu Phe
Val Ser Phe Glu
Val Thr Asp Phe
Val Thr Phe Asp
Val Thr Met Met
Val Tyr Ala Glu
Val Tyr Glu Ala
Tyr Ala Asp Ile
Tyr Ala Asp Leu
Tyr Ala Glu Val
Tyr Ala Ile Asp
Tyr Ala Leu Asp
Tyr Ala Val Glu
Tyr Asp Ala Ile
Tyr Asp Ala Leu
Tyr Asp Ile Ala
Tyr Asp Leu Ala
Tyr Glu Ala Val
Tyr Glu Gly Ile
Tyr Glu Gly Leu
Tyr Glu Ile Gly
Tyr Glu Leu Gly
Tyr Glu Val Ala
Tyr Gly Glu Ile
Tyr Gly Glu Leu
Tyr Gly Ile Glu
Tyr Gly Leu Glu
Tyr Ile Ala Asp
Tyr Ile Asp Ala
Tyr Ile Glu Gly
Tyr Ile Gly Glu
Tyr Leu Ala Asp
Tyr Leu Asp Ala
Tyr Leu Glu Gly
Tyr Leu Gly Glu
Tyr Pro Thr Thr
Tyr Thr Pro Thr
Tyr Thr Thr Pro
Tyr Val Glu Ala
2-[4-(2,2-dicyanovinyl)-N-ethyl-3-methylanilino]-1-(phenoxymethyl)ethyl carbanilate
solifenacin succinate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Solifenacin Succinate (YM905) is a novel muscarinic receptor antagonist with pKis of 7.6, 6.9 and 8.0 for M1, M2 and M3 receptors, respectively.
DIMETHYL 2-(3-FORMYL-4-((2-METHOXYETHOXY)METHOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)SUCCINATE
(3R)-1-azabicyclo[2.2.2]oct-3-yl (1R)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylate succinate
Copanlisib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EM - Phosphatidylinositol-3-kinase (pi3k) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor